These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6456083)

  • 1. Antitumor activity of 3',5'-diesters of 5-fluoro-2'-deoxyuridine against murine leukemia L1210 cells.
    Kanzawa F; Hoshi A; Kuretani K; Saneyoshi M; Kawaguchi T
    Cancer Chemother Pharmacol; 1981; 6(1):19-23. PubMed ID: 6456083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potentiation of the antitumor effect of 5-fluoro-2'-deoxyuridine esters in combination with acyclothymidine esters on L1210 in mice via oral administration.
    Kawaguchi T; Saito M; Saneyoshi M
    J Pharm Sci; 1988 Nov; 77(11):939-43. PubMed ID: 2976090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potentiation by acyclothymidine esters of the antitumor effect of orally administered 5-fluoro-2'-deoxyuridine esters on L1210 in mice.
    Kawaguchi T; Saito M; Saneyoshi M
    Jpn J Cancer Res; 1986 May; 77(5):436-9. PubMed ID: 2942523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor activity of alkylesters of 5-fluoro-2'-deoxyuridine 5'-monophosphate (FdUMP) against murine lymphoma L5178Y resistant to 5-fluoro-2'-deoxyuridine.
    Kanzawa F; Matsushima Y; Ishihara J; Hoshi A; Ohba T; Watanabe K
    J Pharmacobiodyn; 1986 Aug; 9(8):688-93. PubMed ID: 2946859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative physiologic dispositions of 5-fluoro-2'-deoxyuridine and 5-fluorouracil in mice bearing solid L1210 lymphocytic leukemia.
    Chadwick M; Chang C
    Cancer Treat Rep; 1976 Jul; 60(7):845-55. PubMed ID: 137772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxicity of 5-fluoro-5'-O-nitro-2'-deoxyuridine, a new fluorinated pyrimidine derivative, in L1210 cultures.
    Roberts D; Franklin P; Odom G; Peck C; Chwang TL
    Mol Pharmacol; 1982 Nov; 22(3):760-5. PubMed ID: 6218391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Controlled release of 5-fluoro-2'-deoxyuridine by the combination of prodrug and polymer matrix.
    Endoh H; Kawaguchi T; Seki T; Hasegawa T; Juni K
    Chem Pharm Bull (Tokyo); 1991 Feb; 39(2):458-64. PubMed ID: 1829027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folinic acid augmentation of the effects of fluoropyrimidines on murine and human leukemic cells.
    Keyomarsi K; Moran RG
    Cancer Res; 1986 Oct; 46(10):5229-35. PubMed ID: 2944577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity of esterases and structure of prodrug esters. II. Hydrolytic regeneration behavior of 5-fluoro-2'-deoxyuridine (FUdR) from 3',5'-diesters of FUdR with rat tissue homogenates and plasma in relation to their antitumor activity.
    Kawaguchi T; Saito M; Suzuki Y; Nambu N; Nagai T
    Chem Pharm Bull (Tokyo); 1985 Apr; 33(4):1652-9. PubMed ID: 2931191
    [No Abstract]   [Full Text] [Related]  

  • 10. The antitumour effect of lipophilic derivatives of 5-fluoro-2'-deoxyuridine incorporated into liposomes.
    Supersaxo A; Rubas W; Hartmann HR; Schott H; Hengartner H; Schwendener RA
    J Microencapsul; 1988; 5(1):1-11. PubMed ID: 2974073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and biological activity of aromatic amino acid phosphoramidates of 5-fluoro-2'-deoxyuridine and 1-beta-arabinofuranosylcytosine: evidence of phosphoramidase activity.
    Abraham TW; Kalman TI; McIntee EJ; Wagner CR
    J Med Chem; 1996 Nov; 39(23):4569-75. PubMed ID: 8917645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo antitumor effects of fluoropyrimidines on colon adenocarcinoma 38 and enhancement by leucovorin.
    Iigo M; Nishikata K; Hoshi A
    Jpn J Cancer Res; 1992 Apr; 83(4):392-6. PubMed ID: 1387127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluorouracil and derivatives in cancer chemotherapy. 3. In vivo enhancement of antitumor activity of 5-fluorouracil (FU) and 5-fluoro-2'-deoxyuridine (FUDR).
    Jato J; Windheuser JJ
    J Pharm Sci; 1973 Dec; 62(12):1975-8. PubMed ID: 4271579
    [No Abstract]   [Full Text] [Related]  

  • 14. In-vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2'-deoxyuridine and its diacylated derivatives.
    van Borssum Waalkes M; van Galen M; Morselt H; Sternberg B; Scherphof GL
    Biochim Biophys Acta; 1993 May; 1148(1):161-72. PubMed ID: 8499464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effect and tumor level of 5-fluoro-2'-deoxyuridylate following oral administration of tetradecyl 2'-deoxy-5-fluoro-5'-uridylate.
    Nakajima Y; Iigo M; Hoshi A
    Anticancer Drugs; 1992 Jun; 3(3):289-92. PubMed ID: 1525410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the mandibular skeleton in the embryonic chick as evaluated using the DNA-inhibiting agent 5-fluoro-2'-deoxyuridine.
    Hall BK
    J Craniofac Genet Dev Biol; 1987; 7(2):145-59. PubMed ID: 2957385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo distribution and antitumour activity of liposomal 3',5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine.
    Van Borssum Waalkes M; Fichtner I; Dontje B; Lemm M; Becker M; Arndt D; Scherphof GL
    J Microencapsul; 1992; 9(3):335-46. PubMed ID: 1403484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine by guanosine-5'-monophosphate.
    Iigo M; Hoshi A
    J Pharmacobiodyn; 1984 Jan; 7(1):67-9. PubMed ID: 6327964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxicity of liposomal 3'-5'-O-dipalmitoyl-5-fluoro-2'-deoxyuridine in mice.
    van Borssum Waalkes M; Goris H; Dontje BH; Schwendener RA; Scherphof G; Nijhof W
    Anticancer Drug Des; 1998 Jun; 13(4):291-305. PubMed ID: 9627669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.